Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Vertex Announces FDA Clearance of Investigational New Drug Application for VX-407 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Friday, March 22, 2024Vertex Pharmaceuticals Incorporated today announced that the US Food and Drug Administration has cleared the Investigational New Drug Application for VX
Bayer and Thermo Fisher Scientific Collaborate to Increase Patient Access to Precision Cancer Medicines
Thursday, March 21, 2024Bayer AG and Thermo Fisher Scientific Inc today announced to develop nextgeneration sequencing based companion diagnostic assays together These will help identify patients who may benefit from Bayers
Nika Pharmaceuticals, Inc. (NKPH) Merges With Nika Biotechnology, Inc.
Thursday, March 21, 2024Nika Pharmaceuticals Inc announces its merger with Nika BioTechnology Inc effective as of March On August Nika Pharmaceuticals Inc signed a Cooperation Agreement with Nika BioTechnology Inc
Tonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for the Launch and Commercial Manufacture of Tonmya™ for the Management of Fibromyalgia
Thursday, March 21, 2024Tonix Pharmaceuticals Holding Corp a biopharmaceutical company with marketed products and a pipeline of development
Nascent Collaborates With Hypospray Pharma on Proprietary Transdermal Delivery System
Wednesday, March 20, 2024Nascent Biotech Inc a clinicalstage biotechnology Company developing monoclonal antibodies targeting various cancer types and HypoSpray Pharma a clinical and commercial stage drug delivery technology
Aegis Life Receives Investment to Continue Development of DNA-Encoded Therapeutic Antibodies Against Infectious Diseases Using the Fusogenix PLV Platform
Wednesday, March 20, 2024Aegis Life Inc and its parent company Entos Pharmaceuticals announced today that Aegis Life has received a programrelated investment from the Bill Melinda
Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat Cancer
Wednesday, March 20, 2024Fusion Pharmaceuticals Inc a clinicalstage oncology company focused on developing nextgeneration radio conjugates as precision medicines today
RYBREVANT® (Amivantamab-vmjw) Data at ELCC Advance Johnson & Johnson's Ambition to Transform the Standard of Care for Patients With EGFR-mutated Non-small Cell Lung Cancer
Tuesday, March 19, 2024Johnson Johnson announced today that new data will be featured at this years
Bristol Myers Squibb Completes Acquisition of Karuna Therapeutics, Strengthening Neuroscience Portfolio
Tuesday, March 19, 2024Bristol Myers Squibb today announced that it has successfully completed its acquisition of Karuna Therapeutics Inc With the acquisitions completion Karuna shares have ceased trading
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
Monday, March 18, 2024Fennec Pharmaceuticals Inc a commercial stage specialty pharmaceutical company and Norgine a leading European specialist pharmaceutical company
